{"id":16320,"date":"2022-08-31T21:05:33","date_gmt":"2022-08-31T11:05:33","guid":{"rendered":"https:\/\/mvec.mcri.edu.au\/?p=16320"},"modified":"2022-09-01T14:24:05","modified_gmt":"2022-09-01T04:24:05","slug":"atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years","status":"publish","type":"post","link":"https:\/\/mvec.mcri.edu.au\/zh\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\/","title":{"rendered":"ATAGI \u5173\u4e8e 12-17 \u5c81\u9752\u5c11\u5e74\u4f7f\u7528 Novavax \u75ab\u82d7\u7684\u5efa\u8bae"},"content":{"rendered":"<p><span data-contrast=\"none\">ATAGI have now recommended that adolescents aged 12-17 years can receive the Novavax COVID-19 vaccine for their primary course of COVID-19 vaccination. This recommendation provides another vaccine brand option, in addition to Pfizer and Moderna, for individuals in this age group.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">A Novavax primary schedule<\/span> <span data-contrast=\"none\">consists of 2 doses, administered 8 weeks apart. Those with <a href=\"https:\/\/www.health.gov.au\/resources\/publications\/atagi-recommendations-on-the-use-of-a-third-primary-dose-of-covid-19-vaccine-in-individuals-who-are-severely-immunocompromised\" target=\"_blank\" rel=\"noopener\">\u4e25\u91cd\u7684\u514d\u75ab\u529f\u80fd\u4f4e\u4e0b<\/a> should receive 3 doses.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Whilst Novavax is not currently registered for use as a booster dose in adolescents aged 12-17 years, ATAGI advises that it may be used for this purpose, when Pfizer is not suitable for that person.<\/span><\/p>\n<p><span data-contrast=\"none\">To read the recommendations in full please follow the link below.\u00a0<\/span><span data-contrast=\"none\">\u00a0<\/span><br \/>\n<a href=\"https:\/\/www.health.gov.au\/news\/novavax-vaccine-for-adolescents-aged-12-17-years\" target=\"_blank\" rel=\"noopener\"><span data-contrast=\"none\">ATAGI recommendations on the use of the Novavax vaccine for adolescents aged 12-17 years.<\/span><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>In addition to the Moderna and Pfizer COVID-19 vaccines, ATAGI now recommend that adolescents aged 12-17 have the option to receive the Novavax COVID-19 vaccine for their primary course of vaccination. <\/p>","protected":false},"author":493,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_lmt_disableupdate":"no","_lmt_disable":"","footnotes":"","_wp_rev_ctl_limit":""},"categories":[87,10],"tags":[],"class_list":["post-16320","post","type-post","status-publish","format-standard","hentry","category-news","category-external"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ATAGI recommendations on the use of the Novavax vaccine for adolescents aged 12-17 years - The Melbourne Vaccine Education Centre (MVEC)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mvec.mcri.edu.au\/zh\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ATAGI recommendations on the use of the Novavax vaccine for adolescents aged 12-17 years - The Melbourne Vaccine Education Centre (MVEC)\" \/>\n<meta property=\"og:description\" content=\"In addition to the Moderna and Pfizer COVID-19 vaccines, ATAGI now recommend that adolescents aged 12-17 have the option to receive the Novavax COVID-19 vaccine for their primary course of vaccination.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mvec.mcri.edu.au\/zh\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\/\" \/>\n<meta property=\"og:site_name\" content=\"The Melbourne Vaccine Education Centre (MVEC)\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-31T11:05:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-09-01T04:24:05+00:00\" \/>\n<meta name=\"author\" content=\"Alice Black\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alice Black\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\\\/\"},\"author\":{\"name\":\"Alice Black\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/b6f69ebc60314c6d952badec26f9c311\"},\"headline\":\"ATAGI recommendations on the use of the Novavax vaccine for adolescents aged 12-17 years\",\"datePublished\":\"2022-08-31T11:05:33+00:00\",\"dateModified\":\"2022-09-01T04:24:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\\\/\"},\"wordCount\":132,\"articleSection\":[\"Show all\",\"External News\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\\\/\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\\\/\",\"name\":\"ATAGI recommendations on the use of the Novavax vaccine for adolescents aged 12-17 years - The Melbourne Vaccine Education Centre (MVEC)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#website\"},\"datePublished\":\"2022-08-31T11:05:33+00:00\",\"dateModified\":\"2022-09-01T04:24:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/b6f69ebc60314c6d952badec26f9c311\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ATAGI recommendations on the use of the Novavax vaccine for adolescents aged 12-17 years\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#website\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/\",\"name\":\"The Melbourne Vaccine Education Centre (MVEC)\",\"description\":\"Find all your vaccine related infos here.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/b6f69ebc60314c6d952badec26f9c311\",\"name\":\"Alice Black\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/zh\\\/author\\\/alice-black\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ATAGI recommendations on the use of the Novavax vaccine for adolescents aged 12-17 years - The Melbourne Vaccine Education Centre (MVEC)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mvec.mcri.edu.au\/zh\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\/","og_locale":"zh_CN","og_type":"article","og_title":"ATAGI recommendations on the use of the Novavax vaccine for adolescents aged 12-17 years - The Melbourne Vaccine Education Centre (MVEC)","og_description":"In addition to the Moderna and Pfizer COVID-19 vaccines, ATAGI now recommend that adolescents aged 12-17 have the option to receive the Novavax COVID-19 vaccine for their primary course of vaccination.","og_url":"https:\/\/mvec.mcri.edu.au\/zh\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\/","og_site_name":"The Melbourne Vaccine Education Centre (MVEC)","article_published_time":"2022-08-31T11:05:33+00:00","article_modified_time":"2022-09-01T04:24:05+00:00","author":"Alice Black","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"Alice Black","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mvec.mcri.edu.au\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\/#article","isPartOf":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\/"},"author":{"name":"Alice Black","@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/b6f69ebc60314c6d952badec26f9c311"},"headline":"ATAGI recommendations on the use of the Novavax vaccine for adolescents aged 12-17 years","datePublished":"2022-08-31T11:05:33+00:00","dateModified":"2022-09-01T04:24:05+00:00","mainEntityOfPage":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\/"},"wordCount":132,"articleSection":["Show all","External News"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/mvec.mcri.edu.au\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\/","url":"https:\/\/mvec.mcri.edu.au\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\/","name":"ATAGI recommendations on the use of the Novavax vaccine for adolescents aged 12-17 years - The Melbourne Vaccine Education Centre (MVEC)","isPartOf":{"@id":"https:\/\/mvec.mcri.edu.au\/#website"},"datePublished":"2022-08-31T11:05:33+00:00","dateModified":"2022-09-01T04:24:05+00:00","author":{"@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/b6f69ebc60314c6d952badec26f9c311"},"breadcrumb":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mvec.mcri.edu.au\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mvec.mcri.edu.au\/atagi-recommendations-on-the-use-of-the-novavax-vaccine-for-adolescents-aged-12-17-years\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mvec.mcri.edu.au\/"},{"@type":"ListItem","position":2,"name":"ATAGI recommendations on the use of the Novavax vaccine for adolescents aged 12-17 years"}]},{"@type":"WebSite","@id":"https:\/\/mvec.mcri.edu.au\/#website","url":"https:\/\/mvec.mcri.edu.au\/","name":"\u58a8\u5c14\u672c\u75ab\u82d7\u6559\u80b2\u4e2d\u5fc3 (MVEC)","description":"\u5728\u8fd9\u91cc\u627e\u5230\u60a8\u6240\u6709\u7684\u75ab\u82d7\u76f8\u5173\u4fe1\u606f\u3002","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mvec.mcri.edu.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Person","@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/b6f69ebc60314c6d952badec26f9c311","name":"\u827e\u4e3d\u4e1d\u00b7\u5e03\u83b1\u514b","url":"https:\/\/mvec.mcri.edu.au\/zh\/author\/alice-black\/"}]}},"modified_by":"Rachael McGuire","_links":{"self":[{"href":"https:\/\/mvec.mcri.edu.au\/zh\/wp-json\/wp\/v2\/posts\/16320","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mvec.mcri.edu.au\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mvec.mcri.edu.au\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/zh\/wp-json\/wp\/v2\/users\/493"}],"replies":[{"embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/zh\/wp-json\/wp\/v2\/comments?post=16320"}],"version-history":[{"count":0,"href":"https:\/\/mvec.mcri.edu.au\/zh\/wp-json\/wp\/v2\/posts\/16320\/revisions"}],"wp:attachment":[{"href":"https:\/\/mvec.mcri.edu.au\/zh\/wp-json\/wp\/v2\/media?parent=16320"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/zh\/wp-json\/wp\/v2\/categories?post=16320"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/zh\/wp-json\/wp\/v2\/tags?post=16320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}